Jade Biosciences, Inc. (NASDAQ:JBIO) — Market Cap & Net Worth
Market Cap & Net Worth: Jade Biosciences, Inc. (JBIO)
Jade Biosciences, Inc. (NASDAQ:JBIO) has a market capitalization of $917.07 Million ($917.07 Million) as of September 27, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #9336 globally and #2582 in its home market, demonstrating a -19.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jade Biosciences, Inc.'s stock price $14.42 by its total outstanding shares 63597387 (63.60 Million). Also see how large is Jade Biosciences, Inc.'s balance sheet for a full breakdown of the balance sheet.
Jade Biosciences, Inc. Market Cap History: 2025 to 2026
Jade Biosciences, Inc.'s market capitalization history from 2025 to 2026. Data shows growth from $981.31 Million to $917.07 Million (0.00% CAGR). Also see Jade Biosciences, Inc. cash flow conversion for how efficiently the company converts equity into cash flow.
Jade Biosciences, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jade Biosciences, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Jade Biosciences, Inc. share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of JBIO by Market Capitalization
Companies near Jade Biosciences, Inc. in the global market cap rankings as of September 27, 2026. Review how tangible is Jade Biosciences, Inc.'s equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Jade Biosciences, Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #339 globally with a market cap of $79.70 Billion USD.
- CSL Ltd (AU:CSL): Ranked #453 globally with a market cap of $60.74 Billion USD ( AU$85.85 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #507 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $526.19 |
| #339 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.70 Billion | $788.04 |
| #453 | CSL Ltd | AU:CSL | $60.74 Billion | AU$176.95 |
| #507 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $198.88 |
Jade Biosciences, Inc. Historical Marketcap From 2025 to 2026
Between 2025 and today, Jade Biosciences, Inc.'s market cap moved from $981.31 Million to $ 917.07 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $917.07 Million | -6.55% |
| 2025 | $981.31 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 26th, 2026 the market cap of Jade Biosciences, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $917.07 Million USD |
| MoneyControl | $917.07 Million USD |
| MarketWatch | $917.07 Million USD |
| marketcap.company | $917.07 Million USD |
| Reuters | $917.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Jade Biosciences, Inc.
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Ja… Read more